IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Casdin Capital, LLC

Q4 2017 Holdings

Filed 2018-02-14 | 27 holdings | $61.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$25.4M200,00041.3%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$16.9M295,00027.4%
Codexis Inc(CDXS)COM192005106$13.4M1,600,00021.7%
Cytomx Therapeutics Inc(CTMX)COM23284F105$3.7M177,5006.1%
Beigene LTD(ONC)SPONSORED ADR07725L102$1.8M18,0002.9%
Sage Therapeutics Inc(SG7)COM78667J108$41.2K250,0000.1%
Foundation Medicine IncCOM350465100$35.5K520,0000.1%
Loxo Oncology IncCOM548862101$30.3K360,0000.0%
Blueprint Medicines Corp(2L9)COM09627Y109$26.2K348,0000.0%
Bluebird BIO IncCOM09609G100$25.8K145,0000.0%
Myokardia IncCOM62857M105$23.6K560,0000.0%
Sangamo Therapeutics Inc(SGMO)COM800677106$23.0K1,400,0000.0%
Global Blood Therapeutics inCOM37890U108$20.3K515,0000.0%
Voyager Therapeutics Inc(VYGR)COM92915B106$18.8K1,135,0000.0%
Fate Therapeutics Inc(FATE)COM31189P102$15.9K2,600,0000.0%
Spark Therapeutics IncCOM84652J103$15.6K302,4740.0%
Evolent Health Inc(EVH)CL A30050B101$13.3K1,077,5000.0%
Audentes Therapeutics Inc(BOLDEUR)COM05070R104$12.5K400,0000.0%
Genmark Diagnostics Inc(GNMK)COM372309104$11.4K2,730,0000.0%
Illumina Inc(ILMN)COM452327109$9.6K44,0000.0%
Clovis Oncology Inc(CLVSEUR)COM189464100$8.7K127,5000.0%
Jounce Therapeutics Inc(JNCEEUR)COM481116101$6.1K475,0000.0%
Editas Medicine Inc(EDIT)COM28106W103$4.1K133,3330.0%
Syros Pharmaceuticals IncCOM87184Q107$2.7K274,0740.0%
Gilead Sciences Inc(GILD)COM375558103$2.1K30,0000.0%
Ovid Therapeutics Inc(OVID)COM690469101$1.6K160,0000.0%
Agios Pharmaceuticals Inc(AGIO)CallCOM00847X104$1.4K25,0000.0%